1. Neoadjuvant chemotherapy modifies serum pyrrolidone carboxypeptidase specific activity in women with breast cancer and influences circulating levels of GnRH and gonadotropins
   María Jesús Ramírez-Expósito et al, 2020, Breast Cancer Research and Treatment CrossRef
2. Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
   Mark van Barele et al, 2021, Cancers CrossRef
3. Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs
   Maira Huerta-Reyes et al, 2019, Frontiers in Oncology CrossRef
4. The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis
   Carsten Gründker et al, 2017, Frontiers in Endocrinology CrossRef
5. Targeted cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), AEZS-108 (AN-152), inhibits the growth of DU-145 human castration-resistant prostate cancerin vivoandin vitrothrough elevating p21 and ROS levels
   Petra Popovics et al, 2014, Oncotarget CrossRef
6. The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanoma
   Klara Fodor et al, 2020, Oncotarget CrossRef